CARMIEL, Israel (AP) _ Protalix BioTherapeutics Inc. (PLX) on Wednesday reported second-quarter net income of $450,000, after reporting a loss in the same period a year earlier.
The Carmiel, Israel-based company said it had profit of 6 cents per share.
The drug developer posted revenue of $6.4 million in the period.
The company's shares closed at 65 cents. A year ago, they were trading at 64 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX
Keywords: Protalix, Earnings Report